Lead-induced downregulation of soluble guanylate cyclase in isolated rat aortic segments mediated by reactive oxygen species and cyclooxygenase-2

Journal of the American Society of Nephrology

Volumn 14, Issue 6, 2003, Pages 1464-1470

  Courtois, Elise ^a   Marques, Maria ^a,b   Barrientos, Alberto ^a,b   Casado, Santos ^a   López Farré, Antonio ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GUANYLATE CYCLASE; LEAD; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; REACTIVE OXYGEN METABOLITE; ROFECOXIB; SUPEROXIDE;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL WALL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; ENZYME SUBUNIT; EXPOSURE; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR ENDOTHELIUM;

EID: 0038512468     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000064947.14997.69     Document Type: Article

References (33)

1. Sharp DS, Osterloh J, Becker CE, Bernard B, Smith AH, Fisher JM, Syme SL, Holman BL, Johnson T: Blood pressure and blood lead concentration in bus drivers. Environ Health Perspect 78: 131-137, 1988
2. Sharp DS, Becker CE, Smith AH: Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol 2: 210-232, 1987
3. Vaziri ND, Ding Y, Ni Z, Gonick HC: Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy. Kidney Int 52: 1042-1046, 1997
4. Gonick HC, Ding Y, Bondy SC, Ni Z, Vaziri ND: Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension 30: 1487-1492, 1997
5. Vaziri ND, Liang K, Ding Y: Increased NO inactivation and sequestration in lead-induced hypertension. Effect of vitamin E. Kidney Int 56: 1492-1498, 1999
6. Busse R, Mulsch A, Fleming I, Hecker M: Mechanisms of nitric oxide release from the vascular endothelium. Circulation 87: 18-25, 1993
7. Katsuki S, Arnold W, Mittal C, Murad F: Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerine and nitric oxide in various tissue preparations and comparison to the effects of sodium azyde and hychoxylamine. J Cyclic Nucleotide Res 3: 23-35, 1977
8. Gerzer R, Bohme E, Hoffman R, Shultz G: Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 132: 71-74, 1981
9. Buechler WA, Nakane M, Murad F: Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem Biophys Res Commun 174: 351-357, 1991
10. Marques M, Millas I, Jimenez A, García-Collis E, Antonio Rodriguez-Feo J, Velasco S, Barrientos A, Casado S, López-Farté A: Alterations of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertensive rats. J Am Soc Nephrol 12: 2594-2600, 2001
11. Liu H, Force T, Bloch KD: Nerve growth factor decreases soluble guanylate cyclase in rat PC12 cells. J Biol Chem 272: 6038-6043, 1997
12. Arriero MM, Cedrán A, Jimenez P, García A, de la Pinta JC, Manzalbertia F, Muñoz L, Reyero A, Escribano M, Casado S, López Farré A: Aspirin protected the nitricoxide-cyclic GMP generating system in human peritoneum. Peritoneal Dyal Int 21: S48-S53, 2001
13. Parapetropoulos A, Marczin N, Mora G, Milici A, Murad F, Catravas JD: Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA and protein levels by cAMP-elevating agents. Hypertension 26: 696-704, 1995
14. Nakamura T, Sakamoto K: Reactive oxygen species up-regulates cyclooxygenase-2, p53 and Bax mRNA expression in bovine luteral cells. Biochem Biophys Res Commun 284: 203-210, 2001
15. Cheng HF, Wang CJ, Moeckel GN, Zhang MZ, McKanna JA, Harris RC: Cycloxygenase-2 inhibitor blocks expression of mediators of renal injury in model of diabetes and hypertension. Kidney Int 62: 929-939, 2002
16. FitzGerald GA, Patrono C: The coxibs selective inhibitors of cyclooxigenase-2. N Engl J Med 345: 433-442, 2001
17. Sánchez de Miguel L, Casado S, Farré J, García-Durán M, Montón M, Romero J, Rico L, Bellver T, Mata P, Esteban A, López-Farré A: Comparison in vitro effects of trifusal and acetylsalicylic acid on nitric oxide synthesis by human neutrophils. Eur J Pharmacol 343: 57-65, 1998
18. Ding Y, Gonick HC, Vaziri ND: Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypertens 13: 552-555, 2000
19. Vaziri ND, Ding Y: Effect of lead on nitric oxide synthase expression in coronary endothelial cells: Role of superoxide. Hypertension 37: 223-226, 2001
20. --receptor blocked doxazosin. J Hypertens 20: 463-470, 2002
21. Laemmli NK: Change of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
22. Sanchez de Miguel L, Arriero MM, Farré J, Jimenez P, García-Mendez A, de Frutos T, Jimenez A, García R, Cabestrero F, Gomez J, de Andres R, Montón M, Martín E, de la Calle-Lombana LM, Rico L, Romero J, López Farré A: Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: Expression of the nitric oxide synthase isoforms. J Am Coll Cardiol 39: 818-825, 2002
23. Rothe G, Valet G: Flow cytometric analysis of respiratory burst activity in phagocytes which hydroethidine and 2′,7′-dichlorofluorescein. J Leukoc Biol 55: 253-258, 1995
24. Ding Y, Gonick HC, Vaziri ND, Liang K, Wei L: Lead-induced hypertension III. Increased hydroxyl radical production. Am J Hypertens 14: 169-173, 2001
25. Vaziri ND, Ding Y, Ni Z: Compensatory up-regulation of nitric oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Therapeutics 298: 679-685, 2001
26. 91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32, 2000
27. 91phox homologies in vascular smooth muscle cells: nox-1 mediates angiotensin II-induced superoxide formation and redox sensitive signaling pathways. Circ Res 88: 888-894, 2001
28. Pelletier S, Dube J, Villeneuve A, Gobeil F, Yang O, Battistini B, Guillemette G, Sirois P: Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP (4) receptors. Br J Pharmacol 135: 999-1008, 2001
29. 1-subunit gene expression in RFL-6 rat fetal lung fibroblastes. Am J Physiol 265: L456-L461, 1993
30. Nakamura T, Sakamoto K: Reactive oxygen species up-regulates cycloxygenase-2, p53, and Bax mRNA expression in bovine luteal cells. Biochem Biophys Res Commun 284: 203-210, 2001
31. Fang X, Moore AS, Nwankwo J, Weintranb LN, Oberley WL, Snyder DG, Spector A: Induction of cyclooxygenase-2 by over-expression of the human catalase gene in cerebral microvascular endothelial cells. J Neuro Chem 75: 614-623, 2000
32. Zuscik MJ, Pateder DB, Puzas JE, Schiwarz EM, Rosier RN, O'Keefe RJ: Lead alters parathyroid hormone-related peptide and transforming growth factor-beta 1 effects and AP-1 and NF-kappa B signaling in chondrocytes. J Orthop Res 20: 811-818, 2002
33. She H, Xiong S, Lin M, Zandi E, Giulivi C, Tsukamoto H: Iron activates NF-kappa B in Kupffer cells. Am J Physiol 283: G719-G726, 2002